It is extremely important that our grant is cited in all publications resulting from the use of NORC services. Our productivity and effectiveness as a Center is measured in part by the citation of the grant in published work. Please use the following acknowledgement in your publications:
This work utilized Core Services supported by grant DK089503 of NIH to the University of Michigan.
This year marks a milestone in the history of Lipodystrophy Syndromes as there is now an approved form of therapy for the most severe forms of the disease. In addition, 2014 marks the 20th year after the discovery of leptin. The last 20 years have been exciting for both fields during which the research paths have been intertwined repeatedly.
We believe that this is a great time to convene the community of clinicians treating patients with lipodystrophy and patients and families afflicted with these disorders, together with researchers working on adipocyte biology, leptin action and novel metabolic therapeutics development. The purpose of this meeting is to come up with a bold research agenda for the next 10 years, with ambitious goals of discovering new disease mechanisms, and developing novel treatments to cover more ground for the unmet medical need. In order to achieve this, we are making sure that we hear the perspectives of all stakeholders. Therefore, we are reaching out to a diverse group of participants to get together from October 17th through 19th, 2014 for meeting we call “Lipodystrophy in 2014: Leptin and Beyond”. We hope to capture participation from the entire international community and plant the seeds to form an International Clinical Research Network dedicated to the Study of Lipodystrophy (SOLID).
This meeting is catalyzed by an educational grant from Astra Zeneca. We are also reaching out to other pharmaceutical and biotech companies for additional support. We are delighted that we can bring the funding perspectives from NIDDK and the Office of Rare Diseases. The symposium will also be supported by the Michigan Nutrition Obesity Research Center (MNORC) and will serve as its 2014 Annual Symposium.
The scientific Program is being chaired by Dr. Phillip Gorden (NIDDK) and Dr. Abhimanyu Garg (UTSW). The Scientific Organization committee is delighted to extend an official invitation to you to participate. The provisional program (subject to change) is attached for your review. We are hopeful that clinicians seeing lipodystrophy patients and researchers working on all related topics will make time to participate.
We look forward to welcoming everyone in Ann Arbor, Michigan this fall.
On Behalf of Scientific Organization Committee,
Elif A. Oral, MD
Associate Professor of Internal Medicine
Metabolism, Endocrinology and Diabetes Division
Brehm Center for Diabetes
Department of Internal Medicine
University of Michigan, Ann Arbor